The FDA Tuesday unveiled Mystudies app, a new technology to foster the collection of real-world evidence via patients' mobile devices. The agency is releasing the open source code and technical documents that will allow researchers and drug sponsors to customize and use the app to expand the diversity of health information available for clinical trials and studies, while directly capturing the perspective of patients.